Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

51
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
51
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

4.3K
The pathophysiology of pneumonia involves the following steps:
4.3K
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

32
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
32
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

1.3K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K
Human Virome01:26

Human Virome

38
The human body harbors a vast and diverse viral community known as the human virome. The virome includes bacteriophages that infect bacteria, and eukaryotic viruses that infect human cells. Transient dietary and environmental viruses also contribute to this dynamic ecosystem. Estimates suggest the human body may contain on the order of 10¹³ viral particles, though abundance varies widely by body site and detection method.Comprehensive characterization of the virome has become possible...
38
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

4.0K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Viral Detection and Clinical Disease Features in Pediatric Chronic Rhinosinusitis.

Laryngoscope investigative otolaryngology·2026
Same author

Rotavirus Vaccine Coverage and Potential Barriers Among US Children Born From 2007 to 2024.

Pediatrics·2026
Same author

Pneumococcal colonization in pediatric patients undergoing hematopoietic cell transplantation.

Microbiology spectrum·2026
Same author

Pediatric Vaccine Effectiveness Against Influenza Hospitalization and Outpatient Visits: 2021-2024.

Pediatrics·2026
Same author

Epidemiology of HMPV and Other Respiratory Viral Infections Among Outpatients, 2016-2022.

Open forum infectious diseases·2026
Same author

Characteristics of Young Children Hospitalized With Acute Respiratory Failure From Infection With Respiratory Syncytial Virus, SARS-CoV-2, or Both, November 2023-March 2024.

Open forum infectious diseases·2026
Same journal

Structures of the endophytic microbiota during heart rot development in <i>Abies georgei</i> var. <i>smithii</i>.

Microbiology spectrum·2026
Same journal

High <i>Yersinia</i> prevalence in tonsils of wild boars hunted in Northeast Germany using a novel protocol including long cold enrichment.

Microbiology spectrum·2026
Same journal

Genetic variation, recombinant characteristics, and seroprevalence analysis of echovirus 3 causing severe and mild cases of hand, foot, and mouth disease in Guizhou Province.

Microbiology spectrum·2026
Same journal

Mycelial morphology influenced aerobic DNRA in <i>Streptomyces mediolani</i> EM-B2: short rod-shaped mycelium showed markedly greater efficiency than long filamentous mycelium.

Microbiology spectrum·2026
Same journal

Performance and practicality of 16S nanopore sequencing for routine bacterial identification in clinical samples.

Microbiology spectrum·2026
Same journal

Molecular characterization and correlation with β-lactam resistance of penicillin-binding protein2x, 2b, and 1a of <i>Streptococcus pneumoniae</i> in clinical pneumococcal isolates.

Microbiology spectrum·2026
See all related articles

Related Experiment Video

Updated: Apr 8, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

12.7K

Human Metapneumovirus.

Jennifer E Schuster1, John V Williams2

  • 1Department of Pediatrics, Children's Mercy Hospital, Kansas City, MO 64108-4619.

Microbiology Spectrum
|June 25, 2015
PubMed
Summary
This summary is machine-generated.

Human metapneumovirus (HMPV) causes respiratory infections in all ages. Research highlights the fusion (F) protein as a key target for developing effective vaccines and broadly neutralizing antibodies against HMPV and RSV.

More Related Videos

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

8.5K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.8K

Related Experiment Videos

Last Updated: Apr 8, 2026

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

12.7K
An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
09:01

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

8.5K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.8K

Area of Science:

  • Virology
  • Immunology
  • Vaccinology

Background:

  • Human metapneumovirus (HMPV), a paramyxovirus discovered in 2001, is a significant cause of respiratory tract infections in children and adults.
  • Primary HMPV infection typically occurs before age five, with lifelong reinfections common.
  • Four HMPV subgroups exhibit annual variations, and infection by one subgroup offers partial cross-protection.

Purpose of the Study:

  • To review the immunogenicity of HMPV proteins, focusing on the fusion (F) protein as a target for protective antibodies.
  • To explore the potential of monoclonal antibodies (mAbs) targeting the F protein for therapeutic and prophylactic applications.
  • To discuss the implications of identifying broadly neutralizing antibodies common to HMPV and respiratory syncytial virus (RSV).

Main Methods:

  • Review of seroprevalence studies to understand HMPV infection patterns.
  • Analysis of experimental vaccine data in animal and human models to identify antigenic targets.
  • Examination of research on monoclonal antibodies (mAbs) against HMPV and RSV, including epitope mapping.

Main Results:

  • The fusion (F) protein is identified as the primary target for protective antibodies against HMPV.
  • Monoclonal antibodies targeting the F protein demonstrate protective and therapeutic effects in preclinical models.
  • Common epitopes between HMPV and RSV have been identified, leading to the discovery of broadly neutralizing antibodies.

Conclusions:

  • The F protein is a critical target for developing effective HMPV vaccines and antibody-based therapies.
  • Broadly neutralizing antibodies offer promising avenues for prophylaxis and treatment, particularly in high-risk populations.
  • Further research into cross-protective epitopes between HMPV and RSV can advance vaccine development for both viruses.